An Australian study suggests a supervised food challenge may be the best way to diagnose peanut allergy in young children.

Dyve Biosciences targets acidic microenvironments in cancer and inflammatory conditions through transdermal delivery.

A circular RNA (circRNA) drug enhanced saliva production in radiation-induced xerostomia, a promising development in the ...

Europe has world-class biotech research, but can it scale? Nordic Life Science Days explores the capital, expertise, and ...

A 12-year study of more than 52,000 women finds no increased cardiovascular risk with modern hormone replacement therapy started during midlife.

Researchers identify a genetic vulnerability that could enable safer WNT-targeted cancer therapies while sparing healthy cells.

Cervical cancer rates and deaths are increasing around the world, with the highest rates in sub-Saharan Africa.

Five-year trial results support chemotherapy de-escalation in HER2-positive breast cancer, with ctDNA offering additional ...

Phase III findings suggest a promising option for women whose endometrial cancer progresses despite prior chemotherapy and ...

New research identifies molecular signatures in SCLC that could improve immunotherapy outcome prediction beyond conventional staging.

The study followed 4,190 adults with stage 2 hypertension in Pakistan for 12 months, who had their blood pressure continuously monitored using a wrist-worn fitness tracker.

Encoded Therapeutics reports promising early Phase I/II results for its AAV gene therapy developed to treat children with ...